Pasithea Therapeutics Corp. (NASDAQ:KTTA) Sees Large Growth in Short Interest

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 34,500 shares, an increase of 37.5% from the March 31st total of 25,100 shares. Based on an average trading volume of 70,700 shares, the days-to-cover ratio is […]

Related Keywords

,Pasithea Therapeutics Corp ,Vanguard Group Inc ,Exchange Commission ,Ef Hutton Acquisition Co ,Nasdaq ,Pasithea Therapeutics ,Get Rating ,Therapeutics Corp ,Pasithea Therapeutics Daily ,Nasdaq Ktta ,Ktta ,Medical ,Stocks ,Options ,Put ,Call ,